A comparison of intravenous immunoglobulin (2g/kg totally) and single doses of anti-D immunoglobulin at 50μg/kg, 75μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 5, 2013, Pages 505-509

  Alioglu, Bulent ^a   Ercan, Sirma ^a   Tapci, Ayse Esra ^a   Zengin, Tugba ^a   Yazarli, Esra ^a   Dallar, Yildiz ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Anti D immunoglobulin; idiopathic thrombocytopenic purpura; intravenous immunoglobulin

Indexed keywords

RHESUS D ANTIBODY;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; THROMBOCYTE; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN; TURKEY;

EID: 84879950147     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835e5337     Document Type: Article

References (13)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346:995-1008.
2. Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Intercontinental Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001; 358:2122-2125.
3. de Alarcon PA. Immune or idiopathic thrombocytopenic purpura (ITP) in childhood: what are the risks and who should be treated? J Pediatr 2003; 143:287-289.
4. Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, et al. American Society of Pediatric Hematology/Oncology, 2001. Self-reported initial managementofchildhood idiopathicthrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003; 25:130-133.
5. Butros LJ, Bussel JB. Intracranial hemorrhage in immunethrombocytopenic purpura: a retrospective analysis.JPediatr Hematol/Oncol 2003; 25:660-664.
6. Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, et al. Intercontinental Childhood ITP Study Group; Intercontinental Childhood ITP Study Group. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. JPediatr 2003; 143:605-608.
7. Kirovski, Gregoire-Bottex M, Harris ME, Bussel JB. Intracranial hemorrhage in children with acute and chronic immune thrombocytopenic purpura. Blood 2002; 100:480a-481a.
8. Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K, et al. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-centertrial.JPediatr Hematol Oncol 2003; 25:797-800.
9. Shahgholi E, Vosough P, Sotoudeh K, Arjomandi K, Ansari S, Salehi S, et al. Intravenous immune globulin versus intravenous anti-D immune globulin for thetreatment ofacute immunethrombocytopenic purpura. Indian JPediatr 2008; 75:1231-1235.
10. Kane I, Ragucci D, Shatat IF, Bussel J, Kalpatthi R. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura. Br J Haematol 2010; 149:79-83.
11. Papagianni A, Economou M, Tragiannidis A, Karatza E, Tsatra I, Gombakis N, et al. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin inthetreatmentofnewlydiagnosed childhood primary immune thrombocytopenia. J Pediatr Hematol Oncol 2011; 33:265-269.
12. Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. A dose of 75 microg/kg/d ofi.v.anti-Dincreasestheplateletcountmorerapidly and for a longer period of time than 50microg/kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001; 112:1076-1078.
13. Alioglu B, Avci Z, Ozyurek E, Ozbek N. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia. J Pediatr Hematol Oncol 2007; 29:636-669.